US BANCORP \DE\ - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2022$16,000
+1500.0%
7,652
+2442.2%
0.00%
Q1 2022$1,000
-97.3%
301
-95.8%
0.00%
Q4 2021$37,000
+23.3%
7,173
+61.1%
0.00%
Q3 2021$30,000
+172.7%
4,452
+182.3%
0.00%
Q2 2021$11,000
+175.0%
1,577
+135.7%
0.00%
Q1 2021$4,000
-20.0%
669
+24.1%
0.00%
Q4 2020$5,000
-54.5%
539
-44.4%
0.00%
Q3 2020$11,000
+37.5%
970
+108.6%
0.00%
Q2 2020$8,000
-20.0%
465
-70.4%
0.00%
Q1 2020$10,000
+233.3%
1,570
+548.8%
0.00%
Q4 2019$3,0002420.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders